Latest news
Lantheus Holdings, Inc. reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Thu, 06 Aug 2026 13:32:09 GMTLNTH: Q2 revenue up 2.7%, adjusted EPS $1.55, and merger with Curium valued up to $8B announced - TradingViewTradingView · Thu, 06 Aug 2026 12:29:08 GMTLNTH: Q2 2026 saw revenue growth, strategic acquisitions, and a pending merger with Curium - TradingViewTradingView · Thu, 06 Aug 2026 12:03:18 GMTLantheus Q2 revenue rises 2.7%, beats estimates - TradingViewTradingView · Thu, 06 Aug 2026 11:15:47 GMTLantheus to Be Acquired by Curium for $102.50 Cash Plus Up to $12.00 CVR - TradingViewTradingView · Tue, 04 Aug 2026 10:13:00 GMTLantheus Holdings, Inc. Stock 12‑Month Price Target Cut to $110.17, Implies 11% Upside - TradingViewTradingView · Mon, 03 Aug 2026 23:20:04 GMTMRNA, LNTH, BMY, CAPR, RARE Stocks In Focus — These FDA Decisions Could Shape August Trading - TradingViewTradingView · Mon, 03 Aug 2026 21:26:12 GMTLantheus to be acquired by Curium for up to $114.50/share in cash, transaction valued up to $8.0B - TradingViewTradingView · Mon, 03 Aug 2026 12:43:01 GMT